Verve Therapeutics
VERV
#7076
Rank
NZ$0.66 B
Marketcap
$7.87
Share price
1.10%
Change (1 day)
-58.33%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$5.20

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.43. In 2022 the company made an earnings per share (EPS) of -$5.00 a decrease over its 2021 EPS that were of -$4.33.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.204.12%
2022-$5.0015.54%
2021-$4.3361.32%
2020-$2.68